John Trachtenberg MD

Dr. John Trachtenberg is Professor of Surgery and Medical Imaging at the University of Toronto, where he held the Fleck Tanenbaum Chair in Prostatic Diseases at the University of Toronto and University Health Network.

For over 25 years, Dr. Trachtenberg was a uro-oncologist at Toronto General Hospital and the Princess Margaret Cancer Centre, where he was also Director of the Prostate Centre. John received his BSc and MD from McGill University.

Marc B. Garnick, MD

Dr. Marc Garnick is the Gorman Brothers Professor of Medicine at Harvard Medical School (HMS) and the Beth Israel Deaconess Medical Center, where he also directs the Hospital’s role as a tertiary cancer center for many of its affiliated community cancer centers. He completed fellowships at the National Institutes of Health and oncology training and faculty appointments in oncology at the Dana Farber Cancer Institute. He serves as the editor in chief for The HMS Report on Prostate Diseases, and its associated website. He is former a special governmental advisory member of multiple FDA panels and advisory committees. He currently serves on the boards (scientific and corporate) of several life science companies. He has served on the boards of trustees of the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine and is a trustee emeritus of Bowdoin College in Brunswick, Maine.

Amy Lee Chong, MD

Medical Affairs – Global

Dr. Amy Lee Chong is a pediatrician and pediatric hematologist/oncologist with two decades of clinical experience in hospitals such as Our Ladies Children Hospital in Dublin and The Hospital for Sick Children (SickKids) in Toronto. As a former Canadian oncology portfolio medical director and global metastatic breast cancer medical lead for Eli Lilly, she has extensive industry, medical affairs, and commercialization expertise.

Amy also holds Master’s degrees from the University of Toronto (U of T) in Clinical Epidemiology and Healthcare Research and from U of T’s Rotman School of Management in Business Administration in Healthcare and Life Sciences.

Craig Hawker, PhD

Polymers, US

Dr. Craig Hawker is the Co-Director of the California NanoSystems Institute and Director of the Dow Materials Institute at the University of California, Santa Barbara. He is a Distinguished Professor, holds the Alan and Ruth Heeger Chair in Interdisciplinary Science and is the Clarke Professor within the California Nanosystems Institute.

Craig is also an award-winning polymer scientist with 75 US patents and co-authored over 600 papers in nanotechnology, materials science, and chemistry. He holds a BSc from the University of Queensland and a PhD from the University of Cambridge.

Ikennah Browne, MD

Dr. Ikennah Browne is a Thoracic Surgeon at Lakeridge Health and a UBC Master of Health Administration (MHA) alumnus. In 2018, Ikennah co-founded Voyage Biomedical, a medical device company aimed at revolutionizing the treatment of cardiac arrests that was acquired in 2021.

Ikennah earned his undergraduate degree in neuroscience from the University of Toronto and his medical degree from the University of Alberta. He completed surgical training at the University of Calgary and his specialty training in thoracic surgery at St. Joseph’s Hospital in Hamilton, Ontario.

Trevor Reichman, MD

Dr. Reichman is a member of the Abdominal Organ Transplant and HPB Surgery team at the UHN Transplant Program at Toronto General Hospital (TGH). Additionally, he serves as the Surgical Director of the Pancreas Transplant Program and directs the surgical fellowships for abdominal transplantation and HPB surgery at the University of Toronto.

Dr. Reichman completed his General Surgery residency at the University of Chicago Medical Center and then pursued a fellowship in Abdominal Organ Transplantation and HPB Surgery in Toronto.

Karen Burke, PhD

Regulatory

Dr. Karen Burke was most recently Director of Regulatory Affairs, Drug Safety and Quality Assurance at Amgen Canada, and before that, Vice President, Regulatory Affairs at AstraZeneca Canada. She served as President of the 4,000-member Canadian Society for Chemistry during the International Year of Chemistry in 2010-2011. Dr. Burke was an active member of the research-based industry trade associations BIOTECanada and Rx&D (now Innovative Medicines Canada) and a member of the Board of Directors of ethicscentre.ca, the Canadian Centre for Ethics & Corporate Policy.

Karen holds a PhD in organometallic chemistry from McMaster University.

Asimina Arvanitaki, PhD

Physics

Dr. Asimina Arvanitaki is a particle physicist who specializes in designing new experiments at the “precision frontier” of theoretical physics. Dr. Arvanitaki is the Stavros Niarchos Foundation’s Aristarchus Chair in Theoretical Physics and is the first woman to hold a named chair at the Perimeter Institute in Waterloo, Ontario.

In 2016, she received the New Horizons Prize in Fundamental Physics from the Breakthrough Foundation, and in 2022, she won the CAP-TRIUMF Vogt Medal for her work on subatomic physics. Asimina earned her undergraduate degree from the University of Athens and her PhD from Stanford University.

John G. Kelton, MD

Dr. John G. Kelton is a prominent Canadian hematologist and professor at McMaster University in Hamilton, Ontario. He is the Executive Director of the Michael G. DeGroote Initiative for Innovation in Healthcare at McMaster. In recognition of his significant contributions to healthcare and medical research, Dr. Kelton was appointed a Member of the Order of Canada in 2015.

John earned his medical degree from the University of Western Ontario and completed his internal medicine and hematology training at McMaster and Duke University. Joining McMaster University in 1977, he held various roles, including Dean and Vice-President of the Faculty of Health Sciences from 2001 to 2016.